Healthcare provider profile · identity verified

Vinod Kumar Kaura, MD

Internal Medicine · SAN BERNARDINO, CA · NPI 1225117328

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	1041	110
Amlodipine Besylate	Amlodipine Besylate	428	123
Albuterol Sulfate Hfa	Albuterol Sulfate	356	88
Gabapentin	Gabapentin	341	78
Metformin Hcl	Metformin Hcl	319	88
Levothyroxine Sodium	Levothyroxine Sodium	309	84
Atorvastatin Calcium	Atorvastatin Calcium	258	74
Losartan Potassium	Losartan Potassium	257	62
Hydralazine Hcl	Hydralazine Hcl	248	58
Simvastatin	Simvastatin	220	53
Furosemide	Furosemide	214	63
Clonidine Hcl	Clonidine Hcl	180	40
Allopurinol	Allopurinol	177	43
Ibuprofen	Ibuprofen	175	36
Benazepril Hcl	Benazepril Hcl	170	43
Nifedipine Er	Nifedipine	163	32
Omeprazole	Omeprazole	163	34
Pantoprazole Sodium	Pantoprazole Sodium	154	47
Lisinopril	Lisinopril	152	47
Tamsulosin Hcl	Tamsulosin Hcl	142	43
Acetaminophen-Codeine	Acetaminophen With Codeine	139	27
Diclofenac Sodium	Diclofenac Sodium	133	36
Potassium Chloride	Potassium Chloride	128	34
Baclofen	Baclofen	126	23
Carvedilol	Carvedilol	122	31
Trazodone Hcl	Trazodone Hcl	122	27
Clonazepam	Clonazepam	121	19
Metoprolol Succinate	Metoprolol Succinate	116	31
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	115	28
Hydrochlorothiazide	Hydrochlorothiazide	111	29
Rosuvastatin Calcium	Rosuvastatin Calcium	105	33
Metoprolol Tartrate	Metoprolol Tartrate	94	25
Famotidine	Famotidine	93	24
Triamcinolone Acetonide	Triamcinolone Acetonide	93	33
Eliquis	Apixaban	91	20
Fluticasone Propionate	Fluticasone Propionate	91	24
Fenofibrate	Fenofibrate Nanocrystallized	86	19
Lorazepam	Lorazepam	83	14
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	80	20
Finasteride	Finasteride	79	24
Clopidogrel	Clopidogrel Bisulfate	78	23
Meloxicam	Meloxicam	78	26
Warfarin Sodium	Warfarin Sodium	73	suppressed
Januvia	Sitagliptin Phosphate	71	12
Temazepam	Temazepam	70	13
Glimepiride	Glimepiride	67	15
Jardiance	Empagliflozin	67	13
Levetiracetam	Levetiracetam	67	16
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	66	14
Alprazolam	Alprazolam	65	suppressed
Ondansetron Hcl	Ondansetron Hcl	65	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	63	16
Zolpidem Tartrate	Zolpidem Tartrate	61	suppressed
Gemfibrozil	Gemfibrozil	60	suppressed
Ropinirole Hcl	Ropinirole Hcl	57	16
Donepezil Hcl	Donepezil Hcl	56	21
Tramadol Hcl	Tramadol Hcl	56	12
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	52	14
Ozempic	Semaglutide	46	suppressed
Celecoxib	Celecoxib	45	20
Tolterodine Tartrate Er	Tolterodine Tartrate	45	suppressed
Amoxicillin	Amoxicillin	43	31
Cilostazol	Cilostazol	43	suppressed
Prednisone	Prednisone	41	suppressed
Montelukast Sodium	Montelukast Sodium	40	suppressed
Glipizide	Glipizide	38	13
Phenytoin Sodium Extended	Phenytoin Sodium Extended	38	suppressed
Pregabalin	Pregabalin	38	suppressed
Alogliptin	Alogliptin Benzoate	37	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	37	25
Memantine Hcl	Memantine Hcl	36	11
Humulin R	Insulin Regular, Human	34	suppressed
Azithromycin	Azithromycin	33	26
Trulicity	Dulaglutide	33	suppressed
Enalapril Maleate	Enalapril Maleate	32	suppressed
Alendronate Sodium	Alendronate Sodium	31	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	31	22
Carbidopa-Levodopa	Carbidopa/Levodopa	30	suppressed
Labetalol Hcl	Labetalol Hcl	30	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	30	suppressed
Sertraline Hcl	Sertraline Hcl	30	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	29	15
Creon	Lipase/Protease/Amylase	28	suppressed
Lactulose	Lactulose	28	suppressed
Cephalexin	Cephalexin	27	23
Nitroglycerin	Nitroglycerin	27	suppressed
Anastrozole	Anastrozole	26	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	25	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	25	13
Atenolol	Atenolol	24	suppressed
Humulin N	Insulin Nph Human Isophane	23	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	23	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	23	suppressed
Novolog Flexpen	Insulin Aspart	23	suppressed
Risperidone	Risperidone	23	suppressed
Cyproheptadine Hcl	Cyproheptadine Hcl	22	suppressed
Hydrocortisone	Hydrocortisone	22	suppressed
Metronidazole	Metronidazole	22	14
Ulticare Pen Needle	Pen Needle, Diabetic	22	suppressed
Xarelto	Rivaroxaban	22	suppressed
Duloxetine Hcl	Duloxetine Hcl	21	suppressed
Nystatin	Nystatin	21	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	21	suppressed
Ventolin Hfa	Albuterol Sulfate	20	suppressed
Humulin 70-30	Insulin Nph Hum/Reg Insulin Hm	19	suppressed
Levofloxacin	Levofloxacin	18	suppressed
Trueplus Pen Needle	Pen Needle, Diabetic	18	suppressed
Febuxostat	Febuxostat	17	suppressed
Latanoprost	Latanoprost	17	suppressed
Primidone	Primidone	17	suppressed
Acyclovir	Acyclovir	16	suppressed
Aspirin-Dipyridamole Er	Aspirin/Dipyridamole	16	suppressed
Farxiga	Dapagliflozin Propanediol	16	suppressed
Qvar Redihaler	Beclomethasone Dipropionate	16	suppressed
Citalopram Hbr	Citalopram Hydrobromide	15	suppressed
Droplet Pen Needle	Pen Needle, Diabetic	15	suppressed
Pravastatin Sodium	Pravastatin Sodium	15	suppressed
Tobramycin-Dexamethasone	Tobramycin/Dexamethasone	15	suppressed
Buspirone Hcl	Buspirone Hcl	14	suppressed
Divalproex Sodium Er	Divalproex Sodium	14	suppressed
Fluticasone Propionate Hfa	Fluticasone Propionate	14	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	14	suppressed
Lacosamide	Lacosamide	14	suppressed
Loperamide	Loperamide Hcl	14	suppressed
Rasagiline Mesylate	Rasagiline Mesylate	14	suppressed
Topiramate	Topiramate	14	suppressed
Atrovent Hfa	Ipratropium Bromide	13	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	13	suppressed
Fluconazole	Fluconazole	13	suppressed
Humalog Kwikpen U-100	Insulin Lispro	13	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	13	suppressed
Tretinoin	Tretinoin	13	suppressed
Brimonidine Tartrate	Brimonidine Tartrate	12	suppressed
Carisoprodol	Carisoprodol	12	suppressed
Imatinib Mesylate	Imatinib Mesylate	12	suppressed
Nyamyc	Nystatin	12	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	12	12
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	12	suppressed
Alcohol Pads	Alcohol Antiseptic Pads	11	suppressed
Brilinta	Ticagrelor	11	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	11	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	11	suppressed
Methocarbamol	Methocarbamol	11	suppressed
Trueplus Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error